 |
|
Home | Canaccord Genuity Downgrades Edwards Lifesciences (NYSE: EW) |
 |
Canaccord Genuity Downgrades Edwards Lifesciences (NYSE: EW)
|
 |
- September 30, 2010
-
Equities research analysts at Canaccord Genuity downgraded shares of Edwards Lifesciences (NYSE: EW) to a “hold” rating with a price target of $66.00 in a research note to investors on Monday. Edwards Lifesciences Corporation (Edwards Lifesciences) is a global player in products and technologies designed to treat advanced cardiovascular disease. The Company is focused specifically [...]This article (Canaccord Genuity Downgrades Edwards Lifesciences (NYSE: EW)) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://feedproxy.google.com/~r/AmericanBankingNews/~3/x1QFQSYngDw/
|
 |
|
 |
|
 |
